Robert J. Padley - Publications, H-index & Citations

Robert J. Padley

veterans health administration (vha)

26H指数

122论文数

5.3K被引数

收录论文 27

发表时间

ABT-122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin-17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate: A Randomized, Double-Blind Study

ARTHRITIS & RHEUMATOLOGY

IF10.9

2018-10-10

OAAI

Genovese, Mark C.; Weinblatt, Michael E.; Aelion, Jacob A.; Mansikka, Heikki T.; Peloso, Paul M.; Chen, Kun; Li, Yihan; Othman, Ahmed A.; Khatri, Amit; Khan, Nasser S.; Padley, Robert J.

Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis

ARTHRITIS & RHEUMATOLOGY

IF10.9

2017-11-08

OAAI

Fleischmann, Roy M.; Wagner, Frank; Kivitz, Alan J.; Mansikka, Heikki T.; Khan, Nasser; Othman, Ahmed A.; Khatri, Amit; Hong, Feng; Jiang, Ping; Ruzek, Melanie; Padley, Robert J.

ABT-122, A NOVEL DUAL VARIABLE DOMAIN (DVD)-IG™, TARGETING TNF AND IL-17, INHIBITS PERIPHERAL BLOOD MONONUCLEAR CELL PRODUCTION OF GM-CSF AND DECREASES LYMPHOCYTE EXPRESSION OF CXCR4 IN HEALTHY SUBJECTS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-06-01

PREAI

Ruzek, M.; Conlon, D.; Mansikka, H.; Padley, R. J.; Cuff, C.

PHARMACOKINETICS, SAFETY AND TOLERABILITY OF THE SELECTIVE JAK1 INHIBITOR, ABT-494, IN HEALTHY VOLUNTEERS AND SUBJECTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-06-01

PREAI

Mohamed, M. -E.; Camp, H.; Jiang, P.; Padley, R.; Asatryan, A.; Othman, A. A.

PHARMACOKINETICS OF ABT-122, A DUAL TNF- AND IL-17A-TARGETED DVD-IG™, AFTER SINGLE DOSING IN HEALTHY VOLUNTEERS AND MULTIPLE DOSING IN SUBJECTS WITH RHEUMATOID ARTHRITIS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-06-01

PREAI

Ahmed, G. F.; Goss, S.; Jiang, P.; Mansikka, H.; Padley, R. J.; Othman, A. A.

SAFETY, TOLERABILITY, AND FUNCTIONAL ACTIVITY OF ABT-122, A DUAL TNF- AND IL-17A-TARGETED DVD-IG™, FOLLOWING SINGLE-DOSE ADMINISTRATION IN HEALTHY SUBJECTS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2015-06-01

PREAI

Mansikka, H.; Ruzek, M.; Hugunin, M.; Ivanov, A.; Brito, A.; Clabbers, A.; Cuff, C.; Hsieh, C. -M.; Okun, M.; Heuser, R.; Carter, D.; Hendrickson, B.; Pisal, D.; Goss, S.; Liu, J.; Locke, C.; Khan, N.; Padley, R. J.

PHARMACODYNAMICS OF A NOVEL JAK1 SELECTIVE INHIBITOR IN RAT ARTHRITIS AND ANEMIA MODELS AND IN HEALTHY HUMAN SUBJECTS

ANNALS OF THE RHEUMATIC DISEASES

IF20.6

2014-06-01

PREAI

Voss, J.; Graff, C.; Schwartz, A.; Hyland, D.; Argiriadi, M.; Camp, H.; Dowding, L.; Friedman, M.; Frank, K.; George, J.; Goedken, E.; Lo Schiavo, G.; Morytko, M.; O'Brien, R.; Padley, R.; Rozema, M.; Rosebraugh, M.; Stewart, K.; Wallace, G.; Wishart, N.; Murtaza, A.; Olson, L.

Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease The Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) Trial

STROKE

IF8.9

2013-10-01

OAAI

Teo, Koon K.; Goldstein, Larry B.; Chaitman, Bernard R.; Grant, Shannon; Weintraub, William S.; Anderson, David C.; Sila, Cathy A.; Cruz-Flores, Salvador; Padley, Robert J.; Kostuk, William J.; Boden, William E.

Effect of Levosimendan on the Short-Term Clinical Course of Patients With Acutely Decompensated Heart Failure

JACC-HEART FAILURE

IF11.8

2013-04-01

347

OAAI

Packer, Milton; Colucci, Wilson; Fisher, Lloyd; Massie, Barry M.; Teerlink, John R.; Young, James; Padley, Robert J.; Thakkar, Roopal; Delgado-Herrera, Leticia; Salon, Jeffrey; Garratt, Chris; Huang, Bidan; Sarapohja, Toni

Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: Data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial

CRITICAL CARE MEDICINE

IF6

2011-05-01

PREAI

Boehm, Michael; Link, Andreas; Cai, Danlin; Nieminen, Markku S.; Filippatos, Gerasimos S.; Salem, Reda; Solal, Alain Cohen; Huang, Bidan; Padley, Robert J.; Kivikko, Matti; Mebazaa, Alexandre

Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study

EUROPEAN JOURNAL OF HEALTH ECONOMICS

IF3

2009-07-07

OAAI

de Lissovoy, Greg; Fraeman, Kathy; Teerlink, John R.; Mullahy, John; Salon, Jeff; Sterz, Raimund; Durtschi, Amy; Padley, Robert J.

FLUSHING ASSESSMENT TOOL (FAST): PSYCHOMETRIC PROPERTIES OF A NEW MEASURE ASSESSING FLUSHING SYMPTOMS

VALUE IN HEALTH

IF6

2009-05-01

OAAI

Kawata, A. K.; Thakkar, R.; Davidson, M. H.; Punzi, H. A.; Jiang, P.; Li, D.; Krause, S.; Padley, R.; Revicki, D. A.

Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study

JOURNAL OF CLINICAL LIPIDOLOGY

IF4.6

2009-04-01

PREAI

Insull, William, Jr.; Basile, Jan N.; Vo, Anthony N.; Jiang, Ping; Thakkar, Roopal; Padley, Robert J.

Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2009-02-26

138

OAAI

Mebazaa, Alexandre; Nieminen, Markku S.; Filippatos, Gerasimos S.; Cleland, John G.; Salon, Jeffrey E.; Thakkar, Roopal; Padley, Robert J.; Huang, Bidan; Cohen-Solal, Alain

Levosimendan, compared to dobutamine, reduces mortality in patients with a history of heart failure

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2007-06-01

PREAI

Cohen-Solal, A.; Mebazaa, A.; Thakkar, R.; Schulz, G.; Huang, B.; Padley, R. J.

Levosimendan reduces mortality when compared with dobutamine in patients receiving beta blockers

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2007-06-01

PREAI

Mebazaa, A.; Cohen-Solal, A.; Kleber, F. X.; Nieminen, M. S.; Sarapohja, T.; Huang, B.; Thakkar, R.; Padley, R. J.

Clinical composite endpoint classification of REVIVE II corresponds to all-cause mortality risk

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2007-06-01

PREAI

Teerlink, J. R.; Delgado-Herrera, L.; Thakkar, R.; Huang, B.; Padley, R. J.

Patient self-assessments of heart failure status using either categorical or continuous scales were highly correlated in REVIVE I and II

EUROPEAN JOURNAL OF HEART FAILURE

IF10.8

2007-06-01

PREAI

Teerlink, J. R.; Thakkar, R.; Salon, J.; Huang, B.; Padley, R. J.

Levosimendan vs dobutamine for patients with acute decompensated heart failure - The SURVIVE randomized trial

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

IF55

2007-05-02

775

PREAI

Mebazaa, Alexandre; Nieminen, Markku S.; Packer, Milton; Cohen-Solal, Alain; Kleber, Franz X.; Pocock, Stuart J.; Thakkar, Roopal; Padley, Robert J.; Poder, Pentti; Kivikko, Matti

Levosimendan produces a rapid and sustained reduction in plasma B-type natriuretic peptide concentration compared to dobutamine: The SURVIVE study

JOURNAL OF CARDIAC FAILURE

IF8.2

2006-08-01

PREAI

Nieminen, Markku S.; Thakkar, Roopal; Salon, Jeffrey; Padley, Robert; Schulz, Gregory; Mebazaa, Alexandre

研究方向